View Document Preview and Link
Document Date: 2015-01-09 15:38:07 Open Document File Size: 278,80 KB Share Result on Facebook
Company Nashua / / Country United States / / / Event FDA Phase / / Facility Hospital Emergency Departments / Laboratory Response Network / / IndustryTerm food / healthcare providers / / MedicalCondition muscular dystrophy / chronic obstructive pulmonary diseases / influenza-like illness / flu / invasive pneumococcal disease / nausea / patient’s disease / Influenza virus infection / influenza illness / Summary Widespread influenza / progressive illness / milder illness / severe illness / acute uncomplicated influenza / diarrhea / severe influenza / metabolic disorders / illness / influenza / seizure disorders / asthma / spinal cord injury / HIV infection / pneumococcal infections / suspected influenza / vomiting occurring / cerebral palsy / pneumonia / mental retardation / hypertension / very serious illness / H3N2-predominant flu / bronchospasm / annual influenza / influenza infection / bacterial infections / widespread influenza / severe flu illness / drifted H3N2 influenza virus infection / influenza A / stroke / uncomplicated influenza / chronic underlying medical conditions / drifted influenza A / vomiting / diabetes mellitus / influenza viruses / serious flu / sickle cell disease / epilepsy / past influenza / cough / disorders / certain bacterial infections / / MedicalTreatment antibiotics / vaccination / immunosuppression / chemoprophylaxis / / Organization NH Department of Health and Human Services / Centers for Disease Control and Prevention / Epidemiologist Originating Agency / Division of Public Health Services Attachments / U.S. Food and Drug Administration / American Academy of Pediatrics / / Person Benjamin P. Chan / Denise Krol / / / Position Physician / / Product Tamiflu / Relenza / Oral Suspension / Tamiflu® / / ProvinceOrState New Hampshire / / Technology diagnostic tests / / URL http / SocialTag